GLYCATED HEMOGLOBIN (HbA1C) - ANVISA Registration 10303460553

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10303460553 and manufactured by IN VITRO DIAGNOSTICA LTDA. The registration is held by IN VITRO DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10303460553
Registration Details
ANVISA Registration Number: 10303460553
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Família Coluna Cromatográfica (HPLC)
Risk Class II

Registration Details

10303460553

25351913032202401

42837716000198

Company Information

Brazil
PT: BRASIL

Dates and Status

Jan 29, 2024

VIGENTE

09/18/2025 19:00:01